Lv1
10 积分 2024-02-03 加入
Response to programmed cell death protein 1 antibody in patients with Epstein–Barr virus-associated intrahepatic cholangiocarcinoma
1小时前
待确认
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Current status of diagnosis and therapy of hepatoid adenocarcinoma of the gallbladder
5个月前
已完结
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial
6个月前
已完结
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
6个月前
已完结
Modified Linggui Zhugan Decoction () Ameliorates Glycolipid Metabolism and Inflammation via PI3K-Akt/mTOR-S6K1/AMPK-PGC-1 α Signaling Pathways in Obese Type 2 Diabetic Rats
10个月前
已完结
Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy
11个月前
已完结
N6-methyladenosine reader YTHDF1 promotes stemness and therapeutic resistance in hepatocellular carcinoma by enhancing NOTCH1 expression
11个月前
已完结
皖公网安备34019202002308
